Clinical settingPatients presenting with cervical lymphadenopathy who were found to have germ cell tumours.
Participants and Country2 patients. Hong Kong
Study designCase report
Target conditionMetastatic germ cell tumour. Reference standard was a combination of all diagnostic tests, a primary tumour was histopathlogically confirmed in one case.
TestsIHC markers: PLAP, MAK-6, S-100. Serum tumour markers: beta-HCG, AFP.
Follow upNot reported
Proportion with adenocarcinomaNone: both had germ cell tumours
Primary or metastatic tumour?Metastatic
Sample typeCell block made from fine needle aspirate of cervical lymph node.

From: Guideline chapter 2, Diagnosis

Cover of Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin
Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin.
NICE Clinical Guidelines, No. 104.
National Collaborating Centre for Cancer (UK).
Copyright © 2010, National Collaborating Centre for Cancer.

No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licenses issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.